Trials / Terminated
TerminatedNCT00961649
Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination
Safety and IOP-Lowering Efficacy of Brinzolamide/Brimonidine Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma and/or Ocular Hypertension
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 195 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to compare the safety and intraocular pressure (IOP)-lowering efficacy of a new fixed combination of brinzolamide/brimonidine (Brinz/Brim) to: * its individual components (Brinz and Brim), and * the concomitant administration of Brinz and Brim (Brinz+Brim).
Detailed description
This study consisted of 5 visits conducted during 2 sequential phases: the screening/eligibility phase, which included a screening visit and 2 eligibility visits, and the treatment phase, which included 2 on-therapy visits conducted at Week 2 and Week 6 (or early exit). A washout period based on previous ocular medication preceded Eligibility Visit 1. Subjects who met all inclusion/exclusion criteria at both eligibility visits were randomized to 1 of 4 study drug groups for 6 weeks. Study drug instillation began the morning after the second eligibility visit. The study was terminated by the sponsor out of caution due to microgel formation in the Brinz/Brim formulation. 13 remaining active subjects were discontinued. Further analysis revealed that neither the drop size nor the concentration of the active ingredients was affected.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension | |
| DRUG | Brinzolamide ophthalmic suspension, 1% | |
| DRUG | Brimonidine tartrate ophthalmic solution, 0.2% | |
| OTHER | Vehicle | Inactive ingredients used as placebo |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2010-02-01
- Completion
- 2010-02-01
- First posted
- 2009-08-19
- Last updated
- 2013-07-04
- Results posted
- 2013-07-04
Source: ClinicalTrials.gov record NCT00961649. Inclusion in this directory is not an endorsement.